data_2ysv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ysv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.945 0.403 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.971 0.415 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.922 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.923 0.392 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.988 0.423 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.923 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.934 0.397 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.897 0.38 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.928 0.394 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.907 0.384 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.382 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.944 0.402 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 t -129.1 147.83 50.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.828 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.8 m -106.91 165.14 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -99.56 61.63 0.73 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 54.1 p -160.4 166.96 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 4.7 p -104.14 167.37 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.5 4.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.507 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -101.16 106.56 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.18 68.86 2.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.36 -38.06 33.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -62.11 95.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -104.86 48.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.3 p -102.96 154.74 18.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 75.7 170.84 29.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.05 -178.7 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 28.1 t -142.22 142.1 32.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -133.8 166.85 23.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.39 -30.79 16.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.64 2.227 . . . . 0.0 112.4 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.8 t -69.86 110.24 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 4.1 p -139.46 153.07 47.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.486 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 71.8 p -101.85 110.5 22.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.5 p -82.36 -41.71 19.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -60.93 120.46 22.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.2 m -152.95 134.47 14.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.853 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 12.6 t -57.42 112.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -103.92 -29.17 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.03 138.85 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.907 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -165.92 70.23 1.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.29 -44.23 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.285 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.95 86.38 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -134.08 26.13 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -35.3 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -62.89 -169.29 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 56.26 28.35 13.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 32.4 t -101.64 93.6 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -103.77 -175.53 25.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.21 -35.33 5.21 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.7 p -75.46 106.49 7.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 49.1 m -151.59 132.38 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.523 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 29.3 t -80.15 68.36 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 2.3 m -56.19 116.39 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.21 121.69 4.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 66.6 m -121.82 144.85 48.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 90.2 p -89.48 129.85 35.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 104.65 -25.45 25.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.12 48.87 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -139.77 69.75 37.02 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.605 0.716 . . . . 0.0 110.903 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.61 79.61 2.17 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.42 152.09 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -133.18 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 4.2 t -135.58 145.35 46.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.09 -167.3 21.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.26 -40.87 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.9 p -117.78 145.36 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.42 39.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.49 176.53 9.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 6.0 t 60.14 27.5 16.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 90.9 p -67.46 156.22 37.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.486 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.1 t -149.66 174.25 12.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 7.1 t -70.16 85.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -162.24 -76.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 58.1 m -152.89 172.85 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 21.7 m -132.76 89.08 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 133.02 -158.75 23.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -95.11 101.74 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.911 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -173.01 70.43 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.59 -46.61 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.0 98.26 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -68.17 89.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.8 t -167.05 139.18 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.141 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 161.23 -94.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.21 80.99 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.7 p -106.43 164.1 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -107.25 176.77 21.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.51 115.36 4.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.258 . . . . 0.0 112.355 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 75.1 m -122.68 144.46 49.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 5.2 t 58.37 32.96 22.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.486 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -174.72 145.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.872 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.3 p -162.81 175.51 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 68.2 148.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.5 t -162.91 135.93 5.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.82 93.84 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -159.65 107.52 0.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -81.92 171.94 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 54.18 68.37 2.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.76 75.28 3.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -125.17 93.53 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -139.37 118.63 12.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 t -66.63 147.8 52.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 172.76 94.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.55 161.88 26.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 125.91 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -88.15 -176.67 47.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.43 108.31 2.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.643 2.229 . . . . 0.0 112.336 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.5 t -124.58 128.98 49.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.8 t -94.97 -43.2 8.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.463 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -151.53 137.55 18.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 1.4 p -145.24 172.18 13.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -108.46 143.23 16.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.0 t -97.32 118.41 33.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 6.4 t -109.24 -32.66 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -88.36 109.83 3.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.48 116.25 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.895 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.48 71.61 21.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.709 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.44 101.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.655 2.236 . . . . 0.0 112.364 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -156.35 122.53 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.48 67.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 2.5 p -153.85 160.27 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 170.95 -84.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -77.31 -63.1 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.9 t 59.71 34.32 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -179.28 71.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.489 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.77 147.28 10.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.319 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.4 t -98.91 122.94 42.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 8.4 t 59.43 35.66 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.448 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 75.0 m -108.21 118.47 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 90.9 p -146.99 110.68 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -161.92 114.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 30.6 t -60.24 -55.57 32.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 80.0 p -68.93 170.55 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.858 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 96.06 -41.12 2.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.18 169.71 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 68.36 11.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.02 77.4 2.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.389 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -109.56 29.97 7.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -70.02 89.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.4 134.15 56.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.76 61.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.6 87.6 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.8 m -158.32 139.89 13.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -61.42 -172.8 1.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.18 81.96 1.65 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.749 2.299 . . . . 0.0 112.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.2 p -75.63 81.92 2.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.3 t 58.69 54.69 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.475 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 13.6 p -78.9 171.27 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.2 p -82.19 103.88 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -68.23 -146.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.2 p -80.61 104.34 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 1.4 p -161.24 149.15 15.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 163.07 73.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -107.43 -40.86 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -129.16 70.38 81.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 -44.95 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -108.31 129.53 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.1 -56.68 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 35.6 p -61.78 144.61 54.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 149.62 -140.21 7.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -126.5 -63.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 4.8 p 56.21 28.45 13.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -83.15 178.06 53.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.82 120.1 5.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.4 t -94.35 76.45 3.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -151.71 170.16 20.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.452 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 49.8 m -156.62 141.83 17.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.83 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 81.4 p -98.66 129.23 45.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 165.31 90.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 16.5 p -169.52 176.35 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 3.6 m -105.97 177.01 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.21 -42.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 57.54 35.56 25.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -145.13 68.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.33 -42.12 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.381 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -127.87 114.49 17.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -128.93 101.46 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 12.5 t -52.8 -29.61 28.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -56.86 146.92 34.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.36 174.11 10.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.3 p -103.72 -37.89 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 75.95 173.65 35.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -49.04 -49.64 14.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.331 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 89.5 p -92.95 100.66 13.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 p -81.21 164.33 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.103 -0.831 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.5 m -128.96 177.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 5.9 m -124.65 108.15 11.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 168.62 -42.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.6 t -122.96 70.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 17.5 p -69.25 163.32 25.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -59.31 136.06 51.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -112.9 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.56 68.32 73.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.551 0.691 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.4 -175.38 2.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 62.44 34.5 15.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -62.94 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.54 154.77 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 105.29 -82.14 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -108.79 134.69 51.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 5.4 m 60.44 27.5 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -138.85 176.66 20.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -48.68 127.57 16.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.696 2.264 . . . . 0.0 112.389 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.7 t -71.46 -38.77 71.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 59.7 p -81.95 -29.3 32.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.509 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.6 t -112.02 -37.93 4.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.1 m 61.35 52.62 3.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.865 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.83 90.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 10.6 p -108.28 150.8 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 7.7 p -59.74 -50.41 73.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -101.77 -173.66 28.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -123.86 144.91 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -148.2 68.38 10.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.49 74.65 3.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.334 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -123.99 87.93 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -67.03 89.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.8 p -153.71 111.29 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -104.9 -43.12 1.7 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.93 135.59 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 34.1 m -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -135.42 70.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -49.0 -36.83 35.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 86.6 p -93.0 46.57 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.6 p -76.4 -44.74 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.484 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 17.6 m -74.11 92.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 110.837 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 58.4 m -115.23 158.16 22.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 166.59 71.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 89.8 p -102.87 148.84 25.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 35.4 t -61.21 -29.61 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.01 138.08 2.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -76.64 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -126.77 68.34 69.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.62 92.57 0.94 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.642 2.228 . . . . 0.0 112.355 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -130.48 43.03 3.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -67.97 88.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 70.7 p -116.05 152.81 32.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -105.9 -169.63 23.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -100.07 151.78 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 81.5 p -170.2 142.19 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.835 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -92.2 172.87 35.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -49.23 151.38 6.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 41.0 t -66.7 167.21 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 3.4 m -122.86 35.59 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.504 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 7.2 t -107.92 102.58 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 54.9 m -93.68 134.04 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -159.0 93.4 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 3.4 m -109.65 -37.64 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 19.6 m -82.01 97.43 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -106.31 -113.81 3.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.45 173.05 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt 57.31 70.98 1.19 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.563 0.696 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.03 82.6 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.239 . . . . 0.0 112.376 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.31 108.09 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -71.04 88.57 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.0 t -56.7 147.16 23.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.43 -70.47 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.38 155.03 30.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 8.5 t -109.6 100.51 9.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 138.34 75.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.45 161.93 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 47.7 p -87.81 142.05 28.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -129.97 116.05 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.536 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.1 t -160.93 148.11 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.9 t -117.86 -43.69 2.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 109.45 93.35 2.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 35.9 p -98.47 150.68 21.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 29.9 t -160.08 137.47 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 80.28 34.54 29.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.73 40.39 3.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 58.03 68.35 1.9 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.585 0.707 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.58 74.22 3.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.381 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -99.13 106.16 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -129.03 27.07 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 p -100.8 82.64 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -129.24 -108.19 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.88 94.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.8 t -73.1 151.21 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 143.38 -168.87 26.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.76 147.57 13.7 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.1 t -90.44 -68.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 33.0 t -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.525 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.3 t -167.42 175.41 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.6 p -100.25 -52.92 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.06 -135.1 2.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.443 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 2.9 p -107.39 33.67 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 22.7 t -74.77 105.66 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.867 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 144.21 -179.6 21.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.69 123.36 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -171.91 68.31 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.579 0.704 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.67 -25.96 12.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.52 136.09 53.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -142.05 109.68 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.9 t -69.44 132.6 46.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -93.33 -157.03 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -92.74 114.76 27.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.4 t -113.25 137.54 51.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 103.29 -172.34 21.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 97.11 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.1 t -112.44 107.03 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.4 112.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.474 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 96.2 p -112.83 154.09 26.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 52.5 m -108.55 66.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -148.66 -76.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.6 p -119.53 88.4 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 69.2 m -131.42 -56.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -165.52 138.75 5.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -96.36 110.75 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -177.76 69.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.624 0.726 . . . . 0.0 110.94 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.5 -45.79 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -119.56 119.55 34.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -133.13 90.41 2.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.8 t -51.9 -35.41 45.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 130.09 -171.54 20.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.61 114.83 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 49.0 p -70.54 168.37 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 168.4 75.65 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.38 -52.9 7.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.31 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 5.5 t -99.94 129.24 46.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 9.5 t -144.24 155.4 43.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.474 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -146.77 135.32 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.853 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 91.8 p -104.12 83.95 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.69 41.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 29.1 t -93.92 -34.33 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.825 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 50.6 m -53.96 -34.12 58.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -130.1 123.3 3.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -170.73 134.9 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -176.73 69.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.47 -58.23 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.644 2.229 . . . . 0.0 112.356 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 52.59 44.23 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -97.75 -27.14 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 72.5 p -110.56 76.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -173.75 94.99 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -134.19 173.94 11.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 11.1 t -112.46 114.93 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 150.4 -170.35 30.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.13 75.48 3.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.302 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.4 t -117.63 171.93 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 75.2 m -100.7 141.08 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.488 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 53.5 p -88.63 161.25 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.6 m -133.97 106.91 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.66 -152.16 10.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.8 m -114.21 176.45 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 2.5 p -173.34 134.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.22 76.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -128.52 -178.48 4.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -122.18 70.93 32.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.21 -47.27 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.687 2.258 . . . . 0.0 112.353 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 58.33 39.42 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -63.97 -33.11 74.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 13.0 p -56.59 121.96 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -55.86 -64.91 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -92.86 104.71 16.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 94.8 p -159.7 151.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 62.96 173.74 2.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.18 -37.98 3.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.623 2.215 . . . . 0.0 112.345 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 58.6 m -105.44 138.47 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 27.0 m -111.38 85.77 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.078 -0.846 . . . . 0.0 112.45 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 15.5 t -103.95 69.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.5 t -132.7 -43.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -157.61 53.5 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 19.9 m -73.79 98.58 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 11.3 p -143.67 142.56 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 145.27 -151.19 23.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -169.42 108.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.895 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -151.12 71.78 8.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.25 -58.77 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.753 2.302 . . . . 0.0 112.321 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -111.8 85.85 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -68.82 86.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.4 83.98 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -96.17 -41.49 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.35 169.22 3.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 92.3 p -124.5 143.26 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -176.32 73.3 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.83 77.21 2.72 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.2 p -82.8 79.19 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 32.5 t -132.88 50.53 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.476 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 60.2 p -84.86 113.23 21.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.5 t -172.86 158.17 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.95 42.95 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.5 m -80.1 83.78 5.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 34.4 p -93.66 117.64 30.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 173.77 119.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -65.93 113.95 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.73 68.47 74.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.22 -27.57 9.56 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -86.46 88.43 7.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.9 -55.74 2.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 6.7 t -54.9 -30.54 58.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 108.03 -98.19 1.21 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -75.79 164.96 25.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 18.9 m -119.85 99.99 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -152.92 70.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -48.63 151.01 5.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.326 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 39.2 m -52.74 165.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 m -54.09 -67.97 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.152 -0.805 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.945 0.403 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.971 0.415 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 758' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' A' ' 773' ' ' LEU . 61.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' A' ' 766' ' ' ALA . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.72 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 758' ' ' TYR . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.922 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.923 0.392 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 766' ' ' ALA . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.987 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.988 0.423 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.923 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.934 0.397 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.631 HG13 ' HA ' ' A' ' 766' ' ' ALA . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 759' ' ' VAL . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.897 0.38 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 766' ' ' ALA . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.733 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.928 0.394 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 761' ' ' GLN . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.536 ' H ' HG12 ' A' ' 759' ' ' VAL . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 776' ' ' HIS . . . . . 0.414 ' O ' HG22 ' A' ' 779' ' ' VAL . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 776' ' ' HIS . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 766' ' ' ALA . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.907 0.384 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 766' ' ' ALA . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 758' ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' ' 773' ' ' LEU . 21.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 773' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 758' ' ' TYR . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 758' ' ' TYR . . . . . 0.458 ' HA ' HD22 ' A' ' 773' ' ' LEU . 62.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.382 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 773' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 758' ' ' TYR . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.944 0.402 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 766' ' ' ALA . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 766' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 t -129.1 147.83 50.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.828 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.8 m -106.91 165.14 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -99.56 61.63 0.73 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 54.1 p -160.4 166.96 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 4.7 p -104.14 167.37 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.5 4.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.507 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -101.16 106.56 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.18 68.86 2.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.36 -38.06 33.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -62.11 95.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -104.86 48.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.3 p -102.96 154.74 18.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 75.7 170.84 29.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.05 -178.7 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 28.1 t -142.22 142.1 32.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -133.8 166.85 23.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.39 -30.79 16.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.64 2.227 . . . . 0.0 112.4 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.8 t -69.86 110.24 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 4.1 p -139.46 153.07 47.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.486 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 71.8 p -101.85 110.5 22.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.5 p -82.36 -41.71 19.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -60.93 120.46 22.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.2 m -152.95 134.47 14.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.853 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 12.6 t -57.42 112.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -103.92 -29.17 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.03 138.85 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.907 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -165.92 70.23 1.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.29 -44.23 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.285 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.95 86.38 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -134.08 26.13 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -35.3 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -62.89 -169.29 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 56.26 28.35 13.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 32.4 t -101.64 93.6 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -103.77 -175.53 25.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.21 -35.33 5.21 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.7 p -75.46 106.49 7.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 49.1 m -151.59 132.38 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.523 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 29.3 t -80.15 68.36 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 2.3 m -56.19 116.39 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.21 121.69 4.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 66.6 m -121.82 144.85 48.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 90.2 p -89.48 129.85 35.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 104.65 -25.45 25.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.12 48.87 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -139.77 69.75 37.02 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.605 0.716 . . . . 0.0 110.903 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.61 79.61 2.17 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 758' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' A' ' 773' ' ' LEU . 61.0 m-85 -113.42 152.09 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' A' ' 766' ' ' ALA . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.72 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 758' ' ' TYR . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -133.18 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 4.2 t -135.58 145.35 46.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.09 -167.3 21.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.26 -40.87 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.9 p -117.78 145.36 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.42 39.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.49 176.53 9.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 6.0 t 60.14 27.5 16.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 90.9 p -67.46 156.22 37.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.486 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.1 t -149.66 174.25 12.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 7.1 t -70.16 85.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -162.24 -76.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 58.1 m -152.89 172.85 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 21.7 m -132.76 89.08 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 133.02 -158.75 23.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -95.11 101.74 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.911 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -173.01 70.43 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.59 -46.61 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.0 98.26 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -68.17 89.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.8 t -167.05 139.18 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.141 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 161.23 -94.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.21 80.99 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.7 p -106.43 164.1 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -107.25 176.77 21.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.51 115.36 4.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.258 . . . . 0.0 112.355 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 75.1 m -122.68 144.46 49.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 5.2 t 58.37 32.96 22.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.486 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -174.72 145.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.872 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.3 p -162.81 175.51 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 68.2 148.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.5 t -162.91 135.93 5.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.82 93.84 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -159.65 107.52 0.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -81.92 171.94 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 54.18 68.37 2.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.76 75.28 3.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -125.17 93.53 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -139.37 118.63 12.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 t -66.63 147.8 52.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 172.76 94.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.55 161.88 26.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 125.91 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -88.15 -176.67 47.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.43 108.31 2.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.643 2.229 . . . . 0.0 112.336 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.5 t -124.58 128.98 49.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.8 t -94.97 -43.2 8.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.463 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -151.53 137.55 18.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 1.4 p -145.24 172.18 13.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -108.46 143.23 16.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.0 t -97.32 118.41 33.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 6.4 t -109.24 -32.66 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -88.36 109.83 3.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.48 116.25 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.895 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.48 71.61 21.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.709 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.44 101.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.655 2.236 . . . . 0.0 112.364 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -156.35 122.53 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.48 67.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 2.5 p -153.85 160.27 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 170.95 -84.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -77.31 -63.1 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.9 t 59.71 34.32 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -179.28 71.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.489 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.77 147.28 10.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.319 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.4 t -98.91 122.94 42.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 8.4 t 59.43 35.66 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.448 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 75.0 m -108.21 118.47 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 90.9 p -146.99 110.68 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -161.92 114.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 30.6 t -60.24 -55.57 32.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 80.0 p -68.93 170.55 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.858 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 96.06 -41.12 2.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.18 169.71 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 68.36 11.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.02 77.4 2.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.389 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -109.56 29.97 7.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -70.02 89.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.4 134.15 56.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.76 61.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.6 87.6 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.8 m -158.32 139.89 13.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -61.42 -172.8 1.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.18 81.96 1.65 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.749 2.299 . . . . 0.0 112.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.2 p -75.63 81.92 2.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.3 t 58.69 54.69 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.475 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 13.6 p -78.9 171.27 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.2 p -82.19 103.88 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -68.23 -146.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.2 p -80.61 104.34 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 1.4 p -161.24 149.15 15.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 163.07 73.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -107.43 -40.86 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -129.16 70.38 81.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 -44.95 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -108.31 129.53 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 766' ' ' ALA . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.987 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.1 -56.68 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 35.6 p -61.78 144.61 54.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 149.62 -140.21 7.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -126.5 -63.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 4.8 p 56.21 28.45 13.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -83.15 178.06 53.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.82 120.1 5.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.4 t -94.35 76.45 3.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -151.71 170.16 20.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.452 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 49.8 m -156.62 141.83 17.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.83 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 81.4 p -98.66 129.23 45.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 165.31 90.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 16.5 p -169.52 176.35 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 3.6 m -105.97 177.01 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.21 -42.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 57.54 35.56 25.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -145.13 68.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.33 -42.12 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.381 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -127.87 114.49 17.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -128.93 101.46 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 12.5 t -52.8 -29.61 28.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -56.86 146.92 34.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.36 174.11 10.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.3 p -103.72 -37.89 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 75.95 173.65 35.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -49.04 -49.64 14.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.331 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 89.5 p -92.95 100.66 13.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 p -81.21 164.33 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.103 -0.831 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.5 m -128.96 177.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 5.9 m -124.65 108.15 11.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 168.62 -42.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.6 t -122.96 70.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 17.5 p -69.25 163.32 25.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -59.31 136.06 51.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -112.9 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.56 68.32 73.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.551 0.691 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.4 -175.38 2.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 62.44 34.5 15.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -62.94 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.54 154.77 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 105.29 -82.14 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -108.79 134.69 51.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 5.4 m 60.44 27.5 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -138.85 176.66 20.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -48.68 127.57 16.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.696 2.264 . . . . 0.0 112.389 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.7 t -71.46 -38.77 71.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 59.7 p -81.95 -29.3 32.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.509 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.6 t -112.02 -37.93 4.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.1 m 61.35 52.62 3.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.865 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.83 90.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 10.6 p -108.28 150.8 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 7.7 p -59.74 -50.41 73.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -101.77 -173.66 28.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -123.86 144.91 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -148.2 68.38 10.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.49 74.65 3.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.334 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -123.99 87.93 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -67.03 89.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.8 p -153.71 111.29 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -104.9 -43.12 1.7 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.93 135.59 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 34.1 m -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -135.42 70.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -49.0 -36.83 35.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 86.6 p -93.0 46.57 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.6 p -76.4 -44.74 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.484 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 17.6 m -74.11 92.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 110.837 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 58.4 m -115.23 158.16 22.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 166.59 71.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 89.8 p -102.87 148.84 25.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 35.4 t -61.21 -29.61 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.01 138.08 2.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -76.64 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -126.77 68.34 69.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.62 92.57 0.94 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.642 2.228 . . . . 0.0 112.355 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -130.48 43.03 3.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.631 HG13 ' HA ' ' A' ' 766' ' ' ALA . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 759' ' ' VAL . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -67.97 88.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 70.7 p -116.05 152.81 32.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -105.9 -169.63 23.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -100.07 151.78 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 81.5 p -170.2 142.19 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.835 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -92.2 172.87 35.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -49.23 151.38 6.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 41.0 t -66.7 167.21 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 3.4 m -122.86 35.59 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.504 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 7.2 t -107.92 102.58 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 54.9 m -93.68 134.04 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -159.0 93.4 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 3.4 m -109.65 -37.64 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 19.6 m -82.01 97.43 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -106.31 -113.81 3.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.45 173.05 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt 57.31 70.98 1.19 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.563 0.696 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.03 82.6 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.239 . . . . 0.0 112.376 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.31 108.09 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 766' ' ' ALA . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.733 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -71.04 88.57 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.0 t -56.7 147.16 23.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.43 -70.47 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.38 155.03 30.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 8.5 t -109.6 100.51 9.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 138.34 75.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.45 161.93 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 47.7 p -87.81 142.05 28.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -129.97 116.05 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.536 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.1 t -160.93 148.11 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.9 t -117.86 -43.69 2.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 109.45 93.35 2.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 35.9 p -98.47 150.68 21.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 29.9 t -160.08 137.47 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 80.28 34.54 29.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.73 40.39 3.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 58.03 68.35 1.9 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.585 0.707 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.58 74.22 3.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.381 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -99.13 106.16 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 761' ' ' GLN . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.536 ' H ' HG12 ' A' ' 759' ' ' VAL . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 776' ' ' HIS . . . . . 0.414 ' O ' HG22 ' A' ' 779' ' ' VAL . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 776' ' ' HIS . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -129.03 27.07 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 p -100.8 82.64 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -129.24 -108.19 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.88 94.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.8 t -73.1 151.21 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 143.38 -168.87 26.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.76 147.57 13.7 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.1 t -90.44 -68.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 33.0 t -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.525 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.3 t -167.42 175.41 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.6 p -100.25 -52.92 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.06 -135.1 2.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.443 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 2.9 p -107.39 33.67 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 22.7 t -74.77 105.66 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.867 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 144.21 -179.6 21.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.69 123.36 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -171.91 68.31 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.579 0.704 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.67 -25.96 12.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.52 136.09 53.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 766' ' ' ALA . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -142.05 109.68 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.9 t -69.44 132.6 46.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -93.33 -157.03 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -92.74 114.76 27.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.4 t -113.25 137.54 51.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 103.29 -172.34 21.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 97.11 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.1 t -112.44 107.03 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.4 112.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.474 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 96.2 p -112.83 154.09 26.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 52.5 m -108.55 66.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -148.66 -76.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.6 p -119.53 88.4 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 69.2 m -131.42 -56.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -165.52 138.75 5.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -96.36 110.75 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -177.76 69.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.624 0.726 . . . . 0.0 110.94 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.5 -45.79 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -119.56 119.55 34.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -133.13 90.41 2.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.8 t -51.9 -35.41 45.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 130.09 -171.54 20.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.61 114.83 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 49.0 p -70.54 168.37 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 168.4 75.65 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.38 -52.9 7.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.31 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 5.5 t -99.94 129.24 46.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 9.5 t -144.24 155.4 43.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.474 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -146.77 135.32 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.853 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 91.8 p -104.12 83.95 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.69 41.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 29.1 t -93.92 -34.33 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.825 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 50.6 m -53.96 -34.12 58.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -130.1 123.3 3.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -170.73 134.9 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -176.73 69.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.47 -58.23 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.644 2.229 . . . . 0.0 112.356 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 52.59 44.23 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 766' ' ' ALA . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -97.75 -27.14 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 72.5 p -110.56 76.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -173.75 94.99 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -134.19 173.94 11.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 11.1 t -112.46 114.93 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 150.4 -170.35 30.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.13 75.48 3.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.302 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.4 t -117.63 171.93 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 75.2 m -100.7 141.08 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.488 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 53.5 p -88.63 161.25 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.6 m -133.97 106.91 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.66 -152.16 10.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.8 m -114.21 176.45 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 2.5 p -173.34 134.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.22 76.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -128.52 -178.48 4.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -122.18 70.93 32.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 757' ' ' PRO . . . . . 0.693 ' HB2' HG23 ' A' ' 759' ' ' VAL . 56.8 Cg_endo -75.21 -47.27 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.687 2.258 . . . . 0.0 112.353 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 758' ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' ' 773' ' ' LEU . 21.7 m-85 58.33 39.42 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 757' ' ' PRO . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 773' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 758' ' ' TYR . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -63.97 -33.11 74.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 13.0 p -56.59 121.96 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -55.86 -64.91 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -92.86 104.71 16.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 94.8 p -159.7 151.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 62.96 173.74 2.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.18 -37.98 3.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.623 2.215 . . . . 0.0 112.345 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 58.6 m -105.44 138.47 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 27.0 m -111.38 85.77 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.078 -0.846 . . . . 0.0 112.45 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 15.5 t -103.95 69.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.5 t -132.7 -43.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -157.61 53.5 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 19.9 m -73.79 98.58 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 11.3 p -143.67 142.56 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 145.27 -151.19 23.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -169.42 108.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.895 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -151.12 71.78 8.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.25 -58.77 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.753 2.302 . . . . 0.0 112.321 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 758' ' ' TYR . . . . . 0.458 ' HA ' HD22 ' A' ' 773' ' ' LEU . 62.4 m-85 -111.8 85.85 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 773' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 758' ' ' TYR . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -68.82 86.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.4 83.98 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -96.17 -41.49 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.35 169.22 3.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 92.3 p -124.5 143.26 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -176.32 73.3 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.83 77.21 2.72 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.2 p -82.8 79.19 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 32.5 t -132.88 50.53 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.476 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 60.2 p -84.86 113.23 21.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.5 t -172.86 158.17 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.95 42.95 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.5 m -80.1 83.78 5.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 34.4 p -93.66 117.64 30.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 173.77 119.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -65.93 113.95 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.73 68.47 74.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.22 -27.57 9.56 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -86.46 88.43 7.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 766' ' ' ALA . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 766' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.9 -55.74 2.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 6.7 t -54.9 -30.54 58.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 108.03 -98.19 1.21 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -75.79 164.96 25.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 18.9 m -119.85 99.99 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -152.92 70.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -48.63 151.01 5.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.326 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 39.2 m -52.74 165.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 m -54.09 -67.97 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.152 -0.805 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.945 0.403 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.971 0.415 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' A' ' 773' ' ' LEU . 61.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' A' ' 766' ' ' ALA . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.72 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 758' ' ' TYR . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.908 0.385 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.922 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.923 0.392 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 766' ' ' ALA . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.987 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.988 0.423 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.923 0.392 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.934 0.397 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.631 HG13 ' HA ' ' A' ' 766' ' ' ALA . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 759' ' ' VAL . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.897 0.38 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 766' ' ' ALA . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.733 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.928 0.394 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 761' ' ' GLN . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.536 ' H ' HG12 ' A' ' 759' ' ' VAL . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . 0.414 ' O ' HG22 ' A' ' 779' ' ' VAL . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 776' ' ' HIS . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 766' ' ' ALA . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.907 0.384 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 766' ' ' ALA . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' ' 773' ' ' LEU . 21.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 758' ' ' TYR . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . 0.458 ' HA ' HD22 ' A' ' 773' ' ' LEU . 62.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.382 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 758' ' ' TYR . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.944 0.402 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 766' ' ' ALA . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 t -129.1 147.83 50.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.828 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.8 m -106.91 165.14 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -99.56 61.63 0.73 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 54.1 p -160.4 166.96 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 4.7 p -104.14 167.37 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.5 4.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.507 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -101.16 106.56 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.18 68.86 2.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.36 -38.06 33.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -62.11 95.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.71 109.55 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.9 146.61 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.71 -27.01 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -53.84 -52.44 60.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.05 -30.33 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 89.46 57.69 1.73 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -124.18 133.27 53.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.63 173.17 7.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -142.59 129.26 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 11.9 t -66.72 -31.16 71.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -99.24 178.63 4.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 70.9 m -105.31 167.94 9.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 p 55.23 28.21 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.55 -43.78 8.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 29.1 tp -56.77 -27.19 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 17.5 m -57.53 -62.25 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.17 -28.66 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -61.01 -49.41 77.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -57.24 -27.5 62.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -64.79 -40.42 95.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.8 m -107.97 37.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -104.86 48.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.3 p -102.96 154.74 18.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 75.7 170.84 29.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.05 -178.7 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 28.1 t -142.22 142.1 32.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -133.8 166.85 23.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.39 -30.79 16.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.64 2.227 . . . . 0.0 112.4 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.8 t -69.86 110.24 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 4.1 p -139.46 153.07 47.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.486 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 71.8 p -101.85 110.5 22.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.5 p -82.36 -41.71 19.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -60.93 120.46 22.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.2 m -152.95 134.47 14.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.853 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 12.6 t -57.42 112.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -103.92 -29.17 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -136.03 138.85 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.907 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -165.92 70.23 1.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.29 -44.23 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.285 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.95 86.38 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.36 108.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.54 140.14 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -111.46 -27.14 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -53.56 -58.25 7.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 20.7 p -111.47 -26.38 9.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.39 103.37 2.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -172.94 121.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -96.78 166.17 11.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.3 123.8 11.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 19.5 p -111.56 -27.64 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.4 -66.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 75.9 p -140.81 172.04 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 73.0 p -72.47 83.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.34 -26.13 18.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 51.8 tp -52.0 -31.99 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 8.7 t -56.8 -73.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.1 mt -61.6 -27.06 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -66.77 -34.34 77.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -27.92 60.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -73.56 -26.55 60.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 30.4 m -94.02 45.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -134.08 26.13 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -35.3 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -62.89 -169.29 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 56.26 28.35 13.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 32.4 t -101.64 93.6 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -103.77 -175.53 25.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.21 -35.33 5.21 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.7 p -75.46 106.49 7.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 49.1 m -151.59 132.38 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.523 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 29.3 t -80.15 68.36 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 2.3 m -56.19 116.39 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.21 121.69 4.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 66.6 m -121.82 144.85 48.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 90.2 p -89.48 129.85 35.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 104.65 -25.45 25.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.12 48.87 3.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -139.77 69.75 37.02 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.605 0.716 . . . . 0.0 110.903 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.61 79.61 2.17 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' A' ' 773' ' ' LEU . 61.0 m-85 -113.42 152.09 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' A' ' 766' ' ' ALA . 38.8 t -141.86 125.62 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.1 t -65.16 104.97 0.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -83.1 -26.33 31.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -52.22 -63.33 1.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.58 -26.49 15.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 95.03 66.22 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -146.6 125.28 12.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.72 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -103.7 157.26 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -143.75 134.25 24.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 71.9 p -117.9 -29.9 5.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -52.19 -70.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 7.0 p -138.73 -176.77 4.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.4 p -79.57 66.62 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 98.9 m -75.81 -26.77 57.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 758' ' ' TYR . 16.7 tp -51.99 -31.96 31.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.8 m -53.21 -72.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.06 -35.46 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.05 -29.89 65.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -78.15 -26.29 47.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -62.82 -26.92 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 32.9 m -96.26 36.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -133.18 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 4.2 t -135.58 145.35 46.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.09 -167.3 21.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.26 -40.87 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.9 p -117.78 145.36 44.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.42 39.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.49 176.53 9.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 6.0 t 60.14 27.5 16.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 90.9 p -67.46 156.22 37.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.486 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.1 t -149.66 174.25 12.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 7.1 t -70.16 85.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -162.24 -76.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 58.1 m -152.89 172.85 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 21.7 m -132.76 89.08 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 133.02 -158.75 23.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -95.11 101.74 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.911 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -173.01 70.43 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.939 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.59 -46.61 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.0 98.26 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 58.9 t -136.27 129.13 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 11.7 t -81.89 108.24 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -82.23 -26.42 33.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.37 -57.37 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.74 -28.17 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.1 54.48 2.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -122.03 107.11 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -88.06 116.17 26.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -92.95 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 2.0 m 57.78 34.81 24.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.153 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -129.69 -52.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 t -140.41 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 22.5 p -90.59 48.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.84 -28.19 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.0 tp -51.9 -30.42 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.6 t -55.04 -70.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.9 mt -65.67 -36.21 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -56.39 -26.48 53.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -87.58 -26.55 23.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -58.22 -34.07 70.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.35 -25.26 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -68.17 89.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.8 t -167.05 139.18 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.141 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 161.23 -94.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.21 80.99 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.7 p -106.43 164.1 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -107.25 176.77 21.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.51 115.36 4.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.688 2.258 . . . . 0.0 112.355 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 75.1 m -122.68 144.46 49.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 5.2 t 58.37 32.96 22.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.486 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -174.72 145.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.872 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.3 p -162.81 175.51 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 68.2 148.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.5 t -162.91 135.93 5.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.82 93.84 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -159.65 107.52 0.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -81.92 171.94 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 54.18 68.37 2.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.76 75.28 3.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -125.17 93.53 3.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.3 139.48 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.61 135.22 34.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -103.31 -26.37 12.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -52.31 -54.77 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 32.1 p -107.44 -28.42 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.6 72.1 1.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -141.7 127.29 19.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -104.84 157.83 16.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.59 141.36 39.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 13.6 p -119.64 -33.79 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -55.12 -73.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -137.69 -176.85 4.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 40.3 t -76.47 77.84 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.26 -26.45 33.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.12 -30.41 36.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 4.7 t -57.4 -70.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.8 -26.56 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -66.0 -39.43 90.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.806 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -68.1 -28.35 67.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -55.23 -30.8 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.42 43.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -139.37 118.63 12.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 t -66.63 147.8 52.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 172.76 94.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.55 161.88 26.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 125.91 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -88.15 -176.67 47.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.43 108.31 2.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.643 2.229 . . . . 0.0 112.336 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.5 t -124.58 128.98 49.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.8 t -94.97 -43.2 8.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.463 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -151.53 137.55 18.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 1.4 p -145.24 172.18 13.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -108.46 143.23 16.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.0 t -97.32 118.41 33.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 6.4 t -109.24 -32.66 7.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -88.36 109.83 3.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.48 116.25 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.895 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.48 71.61 21.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.709 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.44 101.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.655 2.236 . . . . 0.0 112.364 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -156.35 122.53 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.88 139.2 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 13.4 t -79.49 119.21 22.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.47 40.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -130.71 -43.43 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -115.22 -29.69 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 101.06 76.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -152.91 139.9 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -125.0 141.21 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.95 136.65 54.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 21.1 p -118.65 -29.94 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.6 -47.05 83.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.8 t -160.3 -179.2 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.9 m -80.32 68.74 6.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 8.4 t -80.38 -26.68 38.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.01 -34.09 41.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.4 t -55.11 -73.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.67 -25.29 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.58 -26.03 61.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -82.19 -26.0 33.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -61.54 -30.19 70.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -95.74 31.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -126.48 67.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 2.5 p -153.85 160.27 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 170.95 -84.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -77.31 -63.1 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 1.9 t 59.71 34.32 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -179.28 71.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.489 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.77 147.28 10.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.319 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.4 t -98.91 122.94 42.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 8.4 t 59.43 35.66 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.448 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 75.0 m -108.21 118.47 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 90.9 p -146.99 110.68 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -161.92 114.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 30.6 t -60.24 -55.57 32.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 80.0 p -68.93 170.55 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.858 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 96.06 -41.12 2.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.18 169.71 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 68.36 11.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.559 0.695 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.02 77.4 2.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.389 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -109.56 29.97 7.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.17 130.39 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.4 t -81.96 137.19 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -104.41 -27.6 11.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -52.07 -45.39 64.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.1 p -114.68 -30.43 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 92.27 74.42 1.27 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -145.72 138.33 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -102.94 149.1 24.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -125.35 153.54 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 8.9 t -99.4 -31.03 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.16 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -91.11 179.77 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.96 167.12 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.0 t 57.66 27.49 14.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.819 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -93.0 -47.36 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.8 -28.86 62.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 24.3 m -58.89 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.5 -29.31 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.12 -27.39 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -82.65 -26.86 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -52.23 -34.83 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.3 m -84.19 -27.06 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -70.02 89.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.4 134.15 56.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.76 61.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.6 87.6 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 33.8 m -158.32 139.89 13.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -61.42 -172.8 1.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.18 81.96 1.65 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.749 2.299 . . . . 0.0 112.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.2 p -75.63 81.92 2.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.3 t 58.69 54.69 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.475 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 13.6 p -78.9 171.27 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.2 p -82.19 103.88 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -68.23 -146.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.2 p -80.61 104.34 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 1.4 p -161.24 149.15 15.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 163.07 73.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -107.43 -40.86 5.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -129.16 70.38 81.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.98 -44.95 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -108.31 129.53 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 766' ' ' ALA . 26.2 t -144.47 138.97 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.093 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.62 108.75 17.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -86.99 -25.85 24.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.08 -47.88 64.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.4 p -111.59 -28.55 8.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.67 53.52 1.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 132.73 33.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.987 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -122.45 144.19 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -120.01 134.55 55.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 4.1 p -115.88 -25.27 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.83 -59.36 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.2 t -136.54 174.21 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 35.1 p -83.79 65.46 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.2 t -74.88 -26.53 59.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.34 -30.29 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.9 t -54.94 -72.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 76.9 mt -64.33 -37.19 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -55.82 -26.17 45.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -84.97 -27.71 26.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -60.88 -33.42 73.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.73 -25.76 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.1 -56.68 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 35.6 p -61.78 144.61 54.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 149.62 -140.21 7.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -126.5 -63.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 4.8 p 56.21 28.45 13.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -83.15 178.06 53.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.82 120.1 5.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 2.4 t -94.35 76.45 3.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -151.71 170.16 20.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.452 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 49.8 m -156.62 141.83 17.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.83 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 81.4 p -98.66 129.23 45.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 165.31 90.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 16.5 p -169.52 176.35 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 3.6 m -105.97 177.01 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.21 -42.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 57.54 35.56 25.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -145.13 68.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.33 -42.12 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.381 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -127.87 114.49 17.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 55.3 t -144.57 115.16 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 49.8 t -53.04 142.98 18.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -116.25 -26.72 7.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -53.09 -49.38 66.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -116.18 -26.29 7.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.68 81.16 1.53 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -145.41 141.67 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -116.37 167.02 11.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -142.21 156.66 45.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 73.8 p -77.81 70.24 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 52.26 40.2 28.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 4.4 p -103.65 -178.25 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 16.3 m -116.78 35.49 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 6.5 t -81.83 -26.88 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 61.4 tp -54.55 -32.09 57.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 38.1 t -56.16 -69.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.76 -31.21 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -58.12 -33.26 68.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -77.38 -26.8 52.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -63.27 -28.85 70.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.04 37.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -128.93 101.46 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 12.5 t -52.8 -29.61 28.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -56.86 146.92 34.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.493 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.36 174.11 10.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.373 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.3 p -103.72 -37.89 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 75.95 173.65 35.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -49.04 -49.64 14.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.331 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 89.5 p -92.95 100.66 13.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 p -81.21 164.33 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.103 -0.831 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.5 m -128.96 177.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 5.9 m -124.65 108.15 11.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 168.62 -42.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 5.6 t -122.96 70.0 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 17.5 p -69.25 163.32 25.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -59.31 136.06 51.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -112.9 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.56 68.32 73.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.551 0.691 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.4 -175.38 2.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 62.44 34.5 15.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 47.7 t -73.44 116.48 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.62 105.92 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -88.09 -26.04 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.07 -46.24 65.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 31.6 p -112.27 -28.73 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 94.22 77.6 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.505 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -162.12 114.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -79.54 169.15 18.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -143.8 172.56 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 3.2 p -94.82 -44.85 7.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -103.69 167.14 9.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 65.2 p -96.98 26.62 4.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.7 m -115.35 -27.55 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 49.9 m -63.55 -47.11 82.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.0 tp -54.87 -27.38 42.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 14.9 t -61.36 -69.38 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.21 -26.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -69.02 -26.2 64.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -89.4 -27.41 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -56.38 -28.88 60.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.26 -25.98 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -62.94 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 5.5 t -58.54 154.77 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 105.29 -82.14 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -108.79 134.69 51.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 5.4 m 60.44 27.5 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -138.85 176.66 20.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -48.68 127.57 16.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.696 2.264 . . . . 0.0 112.389 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.7 t -71.46 -38.77 71.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 59.7 p -81.95 -29.3 32.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.092 -0.838 . . . . 0.0 112.509 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.6 t -112.02 -37.93 4.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.1 m 61.35 52.62 3.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.865 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.83 90.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 10.6 p -108.28 150.8 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 7.7 p -59.74 -50.41 73.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -101.77 -173.66 28.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -123.86 144.91 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -148.2 68.38 10.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.49 74.65 3.67 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.659 2.239 . . . . 0.0 112.334 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -123.99 87.93 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.96 130.7 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.15 113.47 13.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.14 -26.29 21.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -52.35 -50.11 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.68 -26.9 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 98.79 28.24 7.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -92.28 132.98 36.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -124.12 146.77 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.85 177.62 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 7.7 m -114.84 -67.94 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.89 75.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 6.5 p -173.28 165.82 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 37.3 p -113.86 31.02 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 15.2 m -56.25 -26.58 52.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 22.9 tp -53.1 -34.07 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 68.9 m -53.64 -73.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.67 -31.68 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.24 -26.62 68.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 41.4 mtp85 -84.3 -26.36 28.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -74.87 -35.89 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.03 -25.33 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -67.03 89.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.8 p -153.71 111.29 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -104.9 -43.12 1.7 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.93 135.59 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 34.1 m -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -135.42 70.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -49.0 -36.83 35.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 86.6 p -93.0 46.57 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 1.6 p -76.4 -44.74 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.484 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 17.6 m -74.11 92.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 110.837 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 58.4 m -115.23 158.16 22.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 166.59 71.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 89.8 p -102.87 148.84 25.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 35.4 t -61.21 -29.61 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.01 138.08 2.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -76.64 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -126.77 68.34 69.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 110.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.62 92.57 0.94 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.642 2.228 . . . . 0.0 112.355 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -130.48 43.03 3.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.631 HG13 ' HA ' ' A' ' 766' ' ' ALA . 44.1 t -61.34 112.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 40.1 t -52.2 140.15 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -105.22 -26.43 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.9 -38.88 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.4 p -117.49 -30.46 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 90.8 46.78 3.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.442 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -122.59 134.15 54.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.331 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 759' ' ' VAL . . . -74.68 171.32 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -154.71 168.01 28.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 15.1 t -107.13 -27.35 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -108.91 178.61 4.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.57 -30.66 7.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -74.69 -30.5 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.812 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 17.8 p -57.88 -32.85 68.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.69 -31.79 71.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 49.3 m -53.13 -70.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.37 -30.11 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.07 -26.71 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -84.2 -26.32 28.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -59.05 -36.08 74.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.32 -25.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -67.97 88.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 70.7 p -116.05 152.81 32.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -105.9 -169.63 23.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -100.07 151.78 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 81.5 p -170.2 142.19 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.835 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -92.2 172.87 35.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -49.23 151.38 6.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 41.0 t -66.7 167.21 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 3.4 m -122.86 35.59 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.504 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 7.2 t -107.92 102.58 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 54.9 m -93.68 134.04 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -159.0 93.4 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 3.4 m -109.65 -37.64 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 19.6 m -82.01 97.43 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -106.31 -113.81 3.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.45 173.05 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt 57.31 70.98 1.19 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.563 0.696 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.03 82.6 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.239 . . . . 0.0 112.376 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.31 108.09 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 766' ' ' ALA . 61.9 t -138.5 138.06 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.3 102.95 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -74.41 -25.5 59.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -52.04 -66.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.78 -30.0 15.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.27 36.44 3.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.21 112.55 25.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.733 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -110.65 153.91 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.03 171.52 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 10.2 p -117.0 -55.01 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -126.53 63.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 2.1 m -173.47 145.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 7.3 m -103.85 34.82 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.08 -26.5 60.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 15.6 tp -52.03 -30.05 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 7.8 t -55.76 -73.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.79 -38.2 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -56.53 -27.38 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -82.43 -27.8 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.25 -50.96 68.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.68 -26.26 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -71.04 88.57 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 3.0 t -56.7 147.16 23.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -161.43 -70.47 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.38 155.03 30.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 8.5 t -109.6 100.51 9.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 138.34 75.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.45 161.93 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 47.7 p -87.81 142.05 28.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 7.7 t -129.97 116.05 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.536 -179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.1 t -160.93 148.11 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 22.9 t -117.86 -43.69 2.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 109.45 93.35 2.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 35.9 p -98.47 150.68 21.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 29.9 t -160.08 137.47 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 80.28 34.54 29.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.73 40.39 3.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.886 0.374 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 58.03 68.35 1.9 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.585 0.707 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.58 74.22 3.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.381 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -99.13 106.16 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 761' ' ' GLN . 59.0 t -94.28 134.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.536 ' H ' HG12 ' A' ' 759' ' ' VAL . 65.6 mt-30 52.52 31.14 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -130.84 -43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.47 -29.44 6.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 103.95 39.99 2.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -129.5 94.52 3.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -71.66 164.84 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -140.52 173.83 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 28.1 p -92.91 -36.79 12.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.112 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -107.68 151.78 25.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 54.1 p -73.27 -33.53 65.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 10.7 t -64.95 -26.55 68.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -64.13 -38.28 90.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.3 -33.95 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 1.9 m -52.16 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.82 -25.69 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . 0.414 ' O ' HG22 ' A' ' 779' ' ' VAL . 73.4 t60 -70.41 -29.46 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.15 -26.39 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -57.57 -26.49 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 776' ' ' HIS . 28.5 m -100.75 32.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -129.03 27.07 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 10.2 p -100.8 82.64 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -129.24 -108.19 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.88 94.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.8 t -73.1 151.21 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 143.38 -168.87 26.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.76 147.57 13.7 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 29.1 t -90.44 -68.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 33.0 t -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.525 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.3 t -167.42 175.41 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.6 p -100.25 -52.92 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.06 -135.1 2.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.443 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 2.9 p -107.39 33.67 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 22.7 t -74.77 105.66 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.867 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 144.21 -179.6 21.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.69 123.36 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -171.91 68.31 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.579 0.704 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.67 -25.96 12.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.52 136.09 53.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 766' ' ' ALA . 23.7 t -142.01 123.43 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.19 117.48 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -97.43 47.64 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.5 -46.63 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.82 -26.68 8.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 97.49 49.07 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -130.25 127.06 38.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -107.11 159.48 16.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -137.86 169.16 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 81.8 p -75.97 -48.86 19.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -84.18 174.24 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 92.4 p -98.71 -35.91 10.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 5.7 t -65.81 -28.8 69.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.93 -30.09 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.81 -31.57 61.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 22.1 t -58.73 -69.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.2 mt -54.35 -28.89 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -72.9 -33.34 65.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.851 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -73.02 -26.62 61.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -56.78 -31.44 64.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.53 42.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -142.05 109.68 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.9 t -69.44 132.6 46.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -93.33 -157.03 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -92.74 114.76 27.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 2.4 t -113.25 137.54 51.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 103.29 -172.34 21.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 97.11 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 3.1 t -112.44 107.03 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.4 112.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.474 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 96.2 p -112.83 154.09 26.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 52.5 m -108.55 66.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -148.66 -76.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 1.6 p -119.53 88.4 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 69.2 m -131.42 -56.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -165.52 138.75 5.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -96.36 110.75 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -177.76 69.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.624 0.726 . . . . 0.0 110.94 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.5 -45.79 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -119.56 119.55 34.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.59 127.4 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.38 116.71 11.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.85 -25.79 23.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -52.02 -46.82 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 30.5 p -113.34 -29.53 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 93.27 65.2 1.07 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.416 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -144.5 120.15 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -81.85 135.18 35.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -112.61 -177.5 3.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 -56.93 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.129 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -74.47 175.27 7.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 34.5 t -115.42 26.47 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.9 p -129.45 -40.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 10.5 p -53.46 -36.8 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.93 -30.56 69.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 33.3 t -58.4 -69.62 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.47 -25.45 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -75.87 -28.23 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -78.32 -28.58 47.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -27.92 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.32 46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -133.13 90.41 2.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 9.8 t -51.9 -35.41 45.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 130.09 -171.54 20.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.61 114.83 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 49.0 p -70.54 168.37 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 168.4 75.65 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.38 -52.9 7.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.31 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 5.5 t -99.94 129.24 46.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 9.5 t -144.24 155.4 43.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.474 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.4 m -146.77 135.32 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.853 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 91.8 p -104.12 83.95 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.69 41.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 29.1 t -93.92 -34.33 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.825 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 50.6 m -53.96 -34.12 58.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -130.1 123.3 3.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -170.73 134.9 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -176.73 69.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.47 -58.23 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.644 2.229 . . . . 0.0 112.356 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 52.59 44.23 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 766' ' ' ALA . 60.3 t -92.14 137.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 5.4 t -92.12 111.74 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.65 -26.03 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -52.06 -48.98 64.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 25.1 p -110.42 -32.17 7.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 106.37 27.49 5.53 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.466 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -103.29 111.33 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.69 138.4 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -128.02 79.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 32.2 p -69.52 -25.91 64.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -54.95 -74.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 1.6 m -129.52 -176.38 3.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.2 p -81.93 67.18 7.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.35 -26.28 33.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.03 -31.26 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 19.6 m -56.91 -70.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.56 -30.85 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -61.89 -50.87 70.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -56.48 -27.81 58.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -74.06 -33.55 63.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.09 36.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -97.75 -27.14 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 72.5 p -110.56 76.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -173.75 94.99 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -134.19 173.94 11.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 11.1 t -112.46 114.93 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 150.4 -170.35 30.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.13 75.48 3.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.302 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 8.4 t -117.63 171.93 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 75.2 m -100.7 141.08 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.488 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 53.5 p -88.63 161.25 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.6 m -133.97 106.91 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -179.66 -152.16 10.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 37.8 m -114.21 176.45 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 2.5 p -173.34 134.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -138.22 76.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -128.52 -178.48 4.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -122.18 70.93 32.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . 0.693 ' HB2' HG23 ' A' ' 759' ' ' VAL . 56.8 Cg_endo -75.21 -47.27 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.687 2.258 . . . . 0.0 112.353 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' ' 773' ' ' LEU . 21.7 m-85 58.33 39.42 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 757' ' ' PRO . 47.4 t -67.76 125.6 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 33.8 t -67.62 109.82 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -81.56 -26.11 35.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -60.85 2.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 29.8 p -98.59 -30.12 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.68 0.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.471 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -141.99 129.22 21.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -103.4 139.57 38.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -127.76 105.94 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 1.4 m -107.94 42.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.75 -52.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 91.0 p -153.34 -179.81 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 58.1 m -78.58 68.83 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 14.2 t -82.88 -27.3 30.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 758' ' ' TYR . 24.0 tp -52.41 -30.09 27.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 20.6 m -56.79 -73.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 60.4 mt -64.89 -32.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.19 -26.38 60.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -86.76 -26.2 24.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 37.4 mmt-85 -62.05 -26.91 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 26.4 m -88.02 -25.35 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -63.97 -33.11 74.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 13.0 p -56.59 121.96 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -55.86 -64.91 3.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -92.86 104.71 16.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 94.8 p -159.7 151.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . 62.96 173.74 2.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.18 -37.98 3.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.623 2.215 . . . . 0.0 112.345 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 58.6 m -105.44 138.47 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 27.0 m -111.38 85.77 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.078 -0.846 . . . . 0.0 112.45 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 15.5 t -103.95 69.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 4.5 t -132.7 -43.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -157.61 53.5 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 19.9 m -73.79 98.58 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 11.3 p -143.67 142.56 31.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 145.27 -151.19 23.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.526 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -169.42 108.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.895 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -151.12 71.78 8.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.25 -58.77 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.753 2.302 . . . . 0.0 112.321 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . 0.458 ' HA ' HD22 ' A' ' 773' ' ' LEU . 62.4 m-85 -111.8 85.85 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.33 117.22 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.57 122.3 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -94.84 -26.04 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -52.06 -42.6 63.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 21.5 p -115.98 -26.24 7.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 91.82 65.77 1.14 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -131.78 107.36 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . . . . . . . . . . . -90.73 166.59 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.065 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -133.01 -178.43 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 91.1 m -99.85 -70.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -134.76 -44.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 16.4 m -55.1 126.73 25.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 m -77.7 67.48 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 36.0 t -78.27 -26.81 47.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 758' ' ' TYR . 14.1 tp -53.18 -30.47 37.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 2.0 t -58.28 -36.23 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.42 -40.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -54.78 -33.58 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -72.67 -25.28 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -67.0 -57.32 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 23.4 m -53.04 -28.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -68.82 86.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.4 83.98 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . -96.17 -41.49 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.35 169.22 3.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 92.3 p -124.5 143.26 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -176.32 73.3 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.83 77.21 2.72 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 1.2 p -82.8 79.19 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 32.5 t -132.88 50.53 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.476 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 60.2 p -84.86 113.23 21.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 3.5 t -172.86 158.17 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.95 42.95 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' SER . . . . . . . . . . . . . 4.5 m -80.1 83.78 5.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' SER . . . . . . . . . . . . . 34.4 p -93.66 117.64 30.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 173.77 119.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -65.93 113.95 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.73 68.47 74.72 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.22 -27.57 9.56 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.665 2.243 . . . . 0.0 112.362 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -86.46 88.43 7.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 1.027 HG13 ' HB2' ' A' ' 766' ' ' ALA . 44.1 t -132.55 107.29 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.57 123.75 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -95.69 -26.25 15.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -52.07 -45.45 64.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.93 -31.56 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' GLY . . . . . . . . . . . . . . . 104.37 28.92 5.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -103.11 101.35 11.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' ALA . . . . . 1.027 ' HB2' HG13 ' A' ' 759' ' ' VAL . . . -101.48 174.45 5.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -147.08 -179.68 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' THR . . . . . . . . . . . . . 39.1 m -121.83 -70.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.15 48.56 2.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' SER . . . . . . . . . . . . . 3.1 m -119.87 -32.95 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 31.78 19.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' LEU . . . . . . . . . . . . . 34.3 tp -51.96 -32.17 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' SER . . . . . . . . . . . . . 11.2 t -53.46 -68.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' ILE . . . . . . . . . . . . . 62.5 mt -65.56 -30.16 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.174 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -52.46 -53.35 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -56.9 -26.24 58.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -73.59 -31.38 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . . . . . . . . . 21.5 m -114.9 30.91 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.9 -55.74 2.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' THR . . . . . . . . . . . . . 6.7 t -54.9 -30.54 58.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' GLY . . . . . . . . . . . . . . . 108.03 -98.19 1.21 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -75.79 164.96 25.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' SER . . . . . . . . . . . . . 18.9 m -119.85 99.99 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' GLY . . . . . . . . . . . . . . . -152.92 70.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -48.63 151.01 5.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.326 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' SER . . . . . . . . . . . . . 39.2 m -52.74 165.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' SER . . . . . . . . . . . . . 2.1 m -54.09 -67.97 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 CA-C-O 119.152 -0.805 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_